U.S. Industrials Stock News

In mid-July 2026, Archer Aviation, BETA Technologies and Macquarie Capital formed the America’s Consortium for Electric Skyways to roll out a standardized CCS-based charging network across up to 250 US air taxi sites, while Archer also introduced Zee, an aviation-specific AI foundation model aimed at improving flight safety and efficiency. By pairing physical eVTOL charging infrastructure with an AI-powered aviation intelligence platform, Archer is positioning itself across both hardware and...

Boeing (BA) is back in focus after securing 173 aircraft orders at the Farnborough Airshow, edging Airbus, and progress on 737 Max 10 and Max 7 safety certifications adds another focal point for investors. See our latest analysis for Boeing. Despite the Farnborough order win and progress on 737 Max certifications, Boeing’s recent share price return has been weak, with the stock down 9.99% over 90 days and the 1 year total shareholder return down 9.53%, suggesting momentum has been fading into...

STAG Industrial (STAG) continues to draw attention after recent trading left the stock around $40.50, prompting investors to reassess this industrial REIT’s long term returns, portfolio scale, and current valuation metrics. See our latest analysis for STAG Industrial. Over the past year, STAG Industrial’s recent pullback, with a 1 day share price return of 1.94% and a 7 day share price return of 3.66%, sits against a 9.7% year to date share price gain and an 18.66% 1 year total shareholder...

GEO Group’s new ICE contract puts Big Horn Facility back in focus GEO Group (GEO) is back in the news after securing a five year support services contract with U.S. Immigration and Customs Enforcement tied to the 1,188 bed Big Horn Facility in Colorado. The agreement, paired with a lease on the facility, is expected to generate about US$85 million in annual revenue in the first full year of operations, excluding transportation revenue. This gives investors fresh information to weigh around...

Strong tanker market and resolved disruptions put Nordic American Tankers in focus Nordic American Tankers (NAT) is back in the spotlight after management highlighted an exceptionally strong tanker market, together with the release of vessels previously trapped in the Arabian Gulf and a minor incident resolved in the Black Sea. See our latest analysis for Nordic American Tankers. At a share price of $6.42, Nordic American Tankers has logged a 90.5% year to date share price return and a...

FirstEnergy’s board previously declared a quarterly dividend of US$0.465 per share, payable on September 1, 2026, to shareholders of record on August 7, 2026, while its Jersey Central Power & Light (JCP&L) subsidiary completed reliability upgrades that have reduced outages and sped up restorations for customers in parts of Somerset County. These past and ongoing investments include more than US$1.00 billion of capital spending by JCP&L last year and a planned US$6.90 billion in New Jersey...

Most small-cap biotech stocks are pure clinical bets. These three already have revenue on the books and insiders backing them with their own capital.

In July 2026, Red Cat Holdings’ board terminated Chief Revenue Officer Geoffrey Hitchcock for cause, prompting Hitchcock to file a civil lawsuit alleging retaliatory termination, breach of contract, and related claims, which the company denies and plans to contest. The board’s decision to withhold severance and equity vesting on a for-cause basis raises important questions about governance, leadership stability, and potential legal overhang for Red Cat. We’ll now examine how the for-cause...

Upstart Holdings has received conditional approval from the US Office of the Comptroller of the Currency to form Upstart Bank, N.A., a Delaware-based, branchless national bank that can originate consumer loans nationwide and accept FDIC-insured deposits once all remaining regulatory approvals and conditions are met. This conditional charter approval marks a milestone in Upstart’s effort to build a fully AI-powered national banking platform, potentially simplifying oversight and funding for...

AMN Healthcare Services has surged 118.7% year to date, yet its broader valuation checks and mixed signals from different methods suggest the stock may no longer be an obvious bargain at current levels. The stock is up 118.7% year to date, which puts extra attention on whether recent gains already reflect most of the value in the business. Interest in AI driven healthcare staffing solutions highlighted by Ardian's investment in Pflegia can support sentiment toward AMN Healthcare Services,...

POET Technologies stock has delivered an 86.7% gain over the past three years, yet its broader valuation checks currently lean expensive, creating a clear tension between past returns and present pricing. Over three years, POET Technologies has returned 86.7%, which puts recent short term share price weakness into the context of a strong longer run. Expectations around POET Technologies’ role in AI related photonics and its recent supply agreements can support higher growth assumptions,...

Wolfspeed stock has retreated sharply over the past month, yet valuation checks still point to a company that screens as expensive rather than a clear bargain. The share price is down about 46.9% over the past month, which has taken some heat out of the rally but has not flipped the story into obvious value territory. Expectations for Wolfspeed's future revenue growth in wide bandgap semiconductors can support a premium, but ongoing investment needs and execution risk around scaling...

Genuine Parts stock has delivered a roughly 15% decline over the past three years, yet current valuation checks suggest a mixed picture rather than a clear bargain or a clear premium after the recent earnings related pullback. Over the past three years, Genuine Parts has declined about 15%, which puts recent price action in the context of a stock that has struggled to generate positive medium term returns. Planned separation of the automotive and industrial businesses may support future...

CRISPR Therapeutics stock has delivered a steep decline of around 60% over the past five years, yet current valuation checks suggest the shares now sit closer to “about right” than clearly cheap or clearly expensive. The roughly 60.1% share price fall over five years raises the question of whether past optimism was too high or whether the market has now become overly cautious on CRISPR Therapeutics. Future value can be heavily influenced by how effectively CRISPR Therapeutics turns its gene...

Royal Caribbean Cruises (RCL) is back in focus after appointing Tara Bunch, a veteran operations leader from Airbnb, Apple and Hewlett-Packard, to its Board, as investors weigh valuation signals and upcoming earnings. See our latest analysis for Royal Caribbean Cruises. Royal Caribbean Cruises shares have eased in the short term, with a 7 day share price return of 3.59% and 30 day share price return of 8.44% from the recent high. However, a 90 day share price return of 6.61% and a 5 year...

In recent days, Silicon Motion Technology has attracted increased attention after analysts significantly raised their earnings estimates and the stock received a top Zacks Rank #1 (Strong Buy) rating, signaling upgraded expectations for its near-term financial performance. This shift in analyst sentiment highlights how improving profit forecasts and external validation can quickly reshape market perceptions of Silicon Motion’s earnings potential. With these upgraded earnings estimates now in...

Globalstar (GSAT) has caught investor attention after recent trading, with the stock showing a year to date gain of 23.75%, alongside a reported annual revenue of $283.02 million and a net loss of $19.35 million. See our latest analysis for Globalstar. While the 1 day and 90 day share price returns for Globalstar are slightly negative, the year to date share price return of 23.75% alongside a very large 1 year total shareholder return of 217.65% suggests momentum has been strong over a longer...

W. R. Berkley (WRB) stock is in focus after the insurer reported stronger than expected Q2 2026 operating income and record net investment income, along with year over year gains in revenue and net income. See our latest analysis for W. R. Berkley. The earnings surprise and record investment income appear to be feeding into stronger momentum for W. R. Berkley, with a 1-day share price return of 1.48%, a 30-day share price return of 6.48%, and a 5-year total shareholder return of 153.06%, all...

Tempus AI has agreed to acquire Personalis (NasdaqGM:PSNL) in a definitive transaction. Following the deal announcement, Monteverde & Associates launched an investigation into the fairness of the transaction terms for Personalis shareholders. Personalis enters this acquisition agreement with Tempus AI with its stock at $12.22 and a very large 3 year return, alongside a 55.7% gain year to date and an 82.1% gain over the past year. The move comes after a mixed longer term picture, with the...

Ardagh Metal Packaging (AMBP) drew fresh attention after reporting second quarter 2026 results that included higher sales, improved earnings and upgraded full year Adjusted EBITDA guidance, along with a quarterly dividend announcement. See our latest analysis for Ardagh Metal Packaging. At a share price of $4.72, Ardagh Metal Packaging has a 90 day share price return of 17.71% and a 1 year total shareholder return of 34.84%. This suggests momentum has picked up recently after a weaker 5 year...

HCA Healthcare (HCA) is under scrutiny after revising its full year 2026 earnings guidance downward, citing a less favorable payer mix and more uninsured patient visits, along with a new securities fraud investigation. See our latest analysis for HCA Healthcare. At a share price of $376.50, HCA Healthcare has seen the share price fall over the past quarter and year to date, even though the 1 year total shareholder return is 11.00% and the 5 year total shareholder return is 58.38%. This...

MasTec (MTZ) is back in focus after recent results highlighted a US$20.33b backlog and strong EPS growth. This points to operational progress that has helped underpin the stock's sharp move over the past six months. See our latest analysis for MasTec. At a share price of US$358.86, MasTec has seen strong share price momentum over the longer term, with a 57.64% year to date share price return and a 97.45% 1 year total shareholder return. However, the 30 day share price return is down 8.09%,...

Futu Holdings has given investors a mixed experience, with the stock sharply down year to date yet still showing a strong 3 year return. The current Excess Returns intrinsic value estimate and market multiples both suggest the shares may be trading below what the fundamentals imply. Over the past 3 years, Futu Holdings has returned 88.9%, which keeps the longer term track record in positive territory despite recent weakness. Expectations for the company’s ability to keep converting growth...

Inspire Medical Systems stock is coming under fresh scrutiny after a steep share price decline over the past few years, while the current valuation checks send a more neutral signal, with the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples no longer flagging an obvious bargain at the latest close near US$50.81. Over the past 3 years, Inspire Medical Systems shareholders have seen the share price fall about 82%, which puts the current valuation discussion front and...